Zimmer Biomet
1,011 hedge funds and large institutions have $24.4B invested in Zimmer Biomet in 2024 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 333 increasing their positions, 385 reducing their positions, and 94 closing their positions.
8% more capital invested
Capital invested by funds: $22.5B → $24.4B (+$1.91B)
1.77% more ownership
Funds ownership: 88.58% → 90.36% (+1.8%)
10% less first-time investments, than exits
New positions opened: 85 | Existing positions closed: 94
2% less funds holding
Funds holding: 1,030 → 1,011 (-19)
14% less repeat investments, than reductions
Existing positions increased: 333 | Existing positions reduced: 385
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
25% less call options, than puts
Call options by funds: $82.7M | Put options by funds: $110M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$618M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$152M |
| 3 |
Millennium Management
New York
|
+$129M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$86.3M |
| 5 |
Goldman Sachs
New York
|
+$56.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$417M |
| 2 |
BlackRock
New York
|
-$179M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$67.2M |
| 4 |
Neuberger Berman Group
New York
|
-$66.4M |
| 5 |
JP Morgan Chase
New York
|
-$43.7M |
ZBH Hedge Fund Activity: Q1 2024 in Review
1,011 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2024, worth a combined $24.4B — up 8.5% from $22.5B a quarter earlier.
Sellers outnumbered buyers: 94 funds closed out of ZBH and 85 opened new positions — a net loss of 9 holders — while 385 trimmed existing stakes and 333 added.
The largest buyer was Dodge & Cox, adding an estimated $618M. The largest seller was Morgan Stanley, cutting an estimated $417M.
- 1,011 institutional investors held Zimmer Biomet (ZBH) as of Q1 2024, down from 1,030 in Q4 2023.
- Funds reported $24.4B of Zimmer Biomet stock for Q1 2024, up 8.5% quarter-over-quarter.
- 85 funds opened new Zimmer Biomet positions in Q1 2024 and 94 closed out, a net change of -9 holders.
- The largest Zimmer Biomet buyer in Q1 2024 was Dodge & Cox, an estimated $618M added.
- The largest Zimmer Biomet seller in Q1 2024 was Morgan Stanley, an estimated $417M sold.
Based on aggregated 13F filings for Q1 2024.